Yishi Corning passed the Shenzhen high-tech enterprise certification

After review by the experts of Shenzhen Science and Technology Innovation Committee, Yishi Kangning was included in the 2014 Shenzhen High-tech Enterprise List on October 16, becoming another high-tech enterprise in Shenzhen.

Since its establishment two years ago, ISKCON has actively responded to the call of the Shenzhen Municipal Government to serve the vast number of cancer patients. The "ACTL targeted anti-tumor cell immune technology" independently developed by the company has reached the international advanced level and is a cutting-edge technology in the field of tumor immunotherapy, and has obtained a number of international and domestic patents.

While focusing on the research and development of ACTL tumor immunotherapy technology, Yishi Kangning is also committed to the promotion and popularization of this technology, hoping to promote the improvement of domestic tumor treatment level and scientific research strength through more clinical applications. Based on the existing technology, talents, teamwork and market advantages, ISKCON will increase research and development efforts to give back to the society and benefit the cancer patients.

"Notice of Shenzhen Municipal Science and Technology Innovation Commission on Publicizing the List of the Second Batch of Shenzhen High-tech Enterprises to Be Recognized in 2014" Original link: http://www.szsti.gov.cn/notices/2014/10/16/1